March 9, 2023

Daily Vitamins Could Prevent The Onset Of Cognitive Impairment

A multivitamin with folic acid, B vitamins, vitamin D, and CoQ10 may slow cognitive decline and neurodegeneration in the elderly.
March 9, 2023

European Proposal For Reduced Vitamin B6 Limit Deemed “Slippery Slope For Free Choice And Self-Care”

Natural health campaigners have critiqued “gross irregularities” in the scientific process used by the European Food Safety Authority (EFSA) to consider halving the safe maximum daily limit of vitamin B6 from supplements.
March 9, 2023

People With Higher Omega-3 Levels Are More Protected From Severe COVID-19 Infection

A new study has found that people with higher omega-3 levels are more protected from severe COVID-19 infection.
March 9, 2023

Study Finds Common Artificial Sweetener Linked To Higher Rates Of Heart Attack And Stroke

New research shows that erythritol, a popular artificial sweetener, is associated with an increased risk of heart attack and stroke.
March 9, 2023

Vitamin E Is An Effective Aid For Sleep In Postmenopausal Women

Researchers have concluded that vitamin E offers potential as an alternative treatment for chronic insomnia disorder in postmenopausal women, as new data suggests it can improve sleep quality, thereby reducing sedative drug use.
March 2, 2023

Governments Hold Detailed Discussions On Proposed Amendments To International Health Regulations

Governments have agreed on a way forward for updating the World Health Organization’s International Health Regulations, holding the first round of intensive discussions on more than 300 amendments proposed by countries.
March 2, 2023

So-called ‘Safe’ Pesticides Have Surprisingly Ill Effects

Health Canada is currently reviewing regulations for pesticides in Canada, and researchers say regulators might want to consider what happened in Japan.
March 2, 2023

European Parliament Chiefs Block Public Scrutiny Of European Commission President Over Pfizer Contract

The top ranks of the European Parliament have slammed the door shut to a public cross-examination of Commission President Ursula von der Leyen over her personal role in negotiating a multibillion-euro vaccine deal with Pfizer.